 |
 |  Antiplatelet Drugs
Goodman & Gilman's Pharmacology > Chapter 54. Blood Coagulation and Anticoagulant, Thrombolytic, and Antiplatelet Drugs > Antiplatelet Drugs |
|
|
 | Abciximab (Reopro)
Clinician's Pocket Reference > Chapter 22. Commonly Used Medications > Generic Drug Data |
|
|
 | Glycoprotein IIb/IIIa Receptor Inhibitor
CURRENT Diagnosis & Treatment in Cardiology > Chapter 4. Unstable Angina/Non-ST Elevation Myocardial Infarction > Treatment > Initial Management > Specific Drug Therapy > Antiplatelet and Anticoagulant Therapy |
|
|
 | Table 109-1 Drugs Definitively Reported to Cause Isolated Thrombocytopeniaa
Harrison's Online > Chapter 109. Disorders of Platelets and Vessel Wall > Disorders of Platelets > Thrombocytopenia > Drug-Induced Thrombocytopenia |
|
|
| Table 238-2 Clinical Use of Antithrombotic Therapy
Harrison's Online > Chapter 238. Unstable Angina and Non-ST-Elevation Myocardial Infarction > Unstable Angina and Non-ST Elevation Myocardial Infarction: Treatment > Antithrombotic Therapy |
|
|
 | Abciximab is a Fab fragment of a murine-human monoclonal antibody that binds to the...
Basic and Clinical Pharmacology > Chapter 55. Immunopharmacology > Immunosuppressive Agents > Monoclonal Antibodies (MABs) > Other MABs |
|
|
 | Glycoprotein Iib/Iiia Antagonists
Williams Hematology > Chapter 110. Thrombocytopenia > Spurious Thrombocytopenia (Pseudothrombocytopenia) |
|
|
 | Abciximab
Hurst's The Heart > Chapter 94. Adverse Cardiovascular Drug Interactions and Complications > Coronary Artery Disease > Antiplatelet Therapy |
|
|
| Abciximab
Goodman & Gilman's Pharmacology > Chapter 54. Blood Coagulation and Anticoagulant, Thrombolytic, and Antiplatelet Drugs > Antiplatelet Drugs > Glycoprotein IIb/IIIa Inhibitors |
|
|
| Adverse Effects
Goodman & Gilman's Pharmacology > Chapter 54. Blood Coagulation and Anticoagulant, Thrombolytic, and Antiplatelet Drugs > Antiplatelet Drugs > Glycoprotein IIb/IIIa Inhibitors |
|
|
 | Complications and Management
Tintinalli's Emergency Medicine > Chapter 224. Anticoagulants, Antiplatelet Agents, and Fibrinolytics > Antiplatelet Agents > Abciximab, Eptifibatide, and Tirofiban |
|
|
| Pharmacology of Glycoprotein IIb-IIIa Receptor Inhibitors
Tintinalli's Emergency Medicine > Chapter 224. Anticoagulants, Antiplatelet Agents, and Fibrinolytics > Antiplatelet Agents > Abciximab, Eptifibatide, and Tirofiban |
|
|
| Because monoclonal antibodies against the GPIIb-IIIa receptor block platelet aggregation by prevent...
Williams Hematology > Chapter 21. Principles of Antithrombotic Therapy > Antiplatelet Drugs > Adenosine Diphosphate Receptor Blockers > GPIIb-IIIa Blockers |
|
|
| The first large clinical trial of abciximab was the Evaluation of c7E3 for the Prevention of Ischem...
Williams Hematology > Chapter 21. Principles of Antithrombotic Therapy > Antiplatelet Drugs > Adenosine Diphosphate Receptor Blockers > GPIIb-IIIa Blockers |
|
|
| Abciximab, a chimeric monoclonal antibody directed against the IIb/IIIa complex including...
Basic and Clinical Pharmacology > Chapter 34. Drugs Used in Disorders of Coagulation > Basic Pharmacology of Antiplatelet Agents > Blockade of Platelet Glycoprotein IIb/IIIa Receptors |
|
|
| Abciximab (ReoPro)
Basic and Clinical Pharmacology > Chapter 55. Immunopharmacology > Preparations Available* |
|
|
| Abciximab(ReoPro)
Basic and Clinical Pharmacology > Chapter 34. Drugs Used in Disorders of Coagulation > Preparations Available |
|
|
| Table 5–3. Standard Intravenous Doses of Commonly Used Agents in Patients with Acute Myocardial Infarction.
CURRENT Diagnosis & Treatment in Cardiology > Chapter 5. Acute Myocardial Infarction > Treatment > Emergency Department Therapy |
|